Key takeaways
Sequencing by expansion (SBX) uses a novel strategy to convert DNA information into Xpandomer molecules, helping to overcome signal-to-noise limitations of current nanopore-based sequencing technologies
When combined with high-throughput arrays and real-time processing—this pore-based technology delivers fast, flexible, and accurate single-molecule sequencing at scale
SBX offers two distinct workflows: SBX-D (duplex sequencing), which provides high accuracy for applications like WGS and oncology, and SBX-S (simplex sequencing), which is optimized for ultra-high throughput and is suited for applications like transcriptome analysis and identifying novel isoforms
A new approach to NGS
Roche has responded to the demand for improved performance by developing a new category of next-generation sequencing (NGS) technology, called sequencing by expansion (SBX). This powerful approach to NGS has been designed for flexibility and performance, with headroom to scale into the future.
Fundamentally, SBX technology converts DNA information into a longer, “expanded” molecule, overcoming the spatial challenges of current nanopore technology and enabling higher signal-to-noise for improved accuracy.1 This expanded molecule, or Xpandomer, is then fed through Roche’s proprietary nanopore, driving single-molecule sequencing at incredibly high rates of speed and facilitating rapid access to usable sequencing data.
Demonstrated research methods
The versatility of the AXELIOS 1 platform has been successfully demonstrated across a broad range of research methods. Its dual sequencing modes provide maximum flexibility to meet your specific project requirements. The SBX-simplex workflow delivers the high throughput required for data-intensive applications, while the SBX-duplex workflow leverages intramolecular consensus to eliminate artifacts and maximize accuracy. Explore the resources below and contact a representative to learn more.
Download our white paper
Germline variant calling using SBX with DeepVariant
Explore how SBX, when coupled with advanced bioinformatics tools like a pangenome aligner and DeepVariant, significantly improves the accuracy of germline variant identification from whole-genome sequencing (WGS) data.
Explore more
For Research Use Only. Not for use in diagnostic procedures. AXELIOS is a trademark of Roche.
References
Wang Y et al. The evolution of nanopore sequencing. Frontiers in Genetics. 2015;5:449. Available from: doi:10.3389/fgene.2014.00449